These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 463369)

  • 21. [Urine surface tension in patients with urolithiasis treated with pharmalite].
    Ivanova M; Georgiev G
    Biofizika; 2002; 47(3):568-9. PubMed ID: 12068618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prevention of recurrence of calculus: results of a regional study].
    Labeeuw M; Pozet N; Martin X; Lareal MC
    Nephrologie; 1989; 10(4):205-7. PubMed ID: 2633068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urolilithiasis, clinic-therapy-prevention].
    Schneider HJ
    Z Gesamte Inn Med; 1971 Apr; 26(8):272-7. PubMed ID: 5565824
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug effects on the degree of activity of colloid in urine in the prevention and treatment of lithiasis of the urinary tract].
    Modliński L
    Pol Przegl Chir; 1969 Aug; 41(8):Suppl 8a:1112+. PubMed ID: 5343559
    [No Abstract]   [Full Text] [Related]  

  • 25. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
    Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of dynamic observation in the prevention of recurrences of stone formation].
    Dzeranov NK; Darenkov AF; Konstantinova OV; Beshliev DA; Borisik VI; Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1998; (2):12-4. PubMed ID: 9577694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A metabolic approach to patients with calculi].
    Wildschutz T; Ekane S; Simon J; Schulman CC
    Acta Urol Belg; 1997 Oct; 65(3):9-14. PubMed ID: 9471888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].
    Musialik D; Głuszek J; Pieczyńska A
    Pol Tyg Lek; 1991 Oct 7-21; 46(40-42):739-42. PubMed ID: 1669148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Socioeconomic aspects of urinary calculi and metaphylaxis of urinary calculi].
    Strohmaier WL
    Urologe A; 2000 Mar; 39(2):166-70. PubMed ID: 10768228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury.
    Donnellan SM; Bolton DM
    BJU Int; 1999 Aug; 84(3):280-5. PubMed ID: 10468722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorthalidone in prevention of urinary calcium stone.
    Sidabutar RP; Lumenta NA; Suling RC
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():195-204. PubMed ID: 627795
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of drugs used for the prevention of urinary calculi recurrence on the growth and metabolism of young experimental animals].
    Schneider HJ; Unger G; Rössler D; Bothor C; Berg W; Ernst G
    Z Urol Nephrol; 1979 Apr; 72(4):237-47. PubMed ID: 111438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urolithiasis].
    Piasecki Z; Wyczółkowski M
    Przegl Lek; 1998; 55(9):485-7. PubMed ID: 10085729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observations on the aetiology of multiple and recurrent urinary calculi with special reference to calculi and phosphorus metabolism.
    Rizvi SN; Khanna SC; Mahajan KC; Vaishnava H
    J Assoc Physicians India; 1973 Feb; 21(2):195-201. PubMed ID: 4792790
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rhythm of diurnal and seasonal urine excretion in calcium oxalate-urinary calculi patients and healthy humans and its effect on the incidence of calculi].
    Schulz E; Brundig P; Pirlich W
    Urologe A; 1984 Mar; 23(2):77-81. PubMed ID: 6539024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Personal experience in the diagnosis and monitoring of therapy in metabolic disorders with risk of crystallization in patients with recurrent urolithiasis].
    Stejskal D; Bártek J; Hrebícek J; Bána J; Zát'ura F; Mohapl P; Terber R
    Vnitr Lek; 1997 Dec; 43(12):781-6. PubMed ID: 9601889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metaphylaxis of urolithiasis in the early postoperative period].
    Kuznetsov AI
    Klin Khir (1962); 1978 Feb; (2):53-7. PubMed ID: 642262
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dietetic aspects of preventing urolithiasis in patients with gout and uric acid diathesis].
    Pak CH; Oleneva VA; Agadzhanov SA
    Vopr Pitan; 1985; (1):21-4. PubMed ID: 3885567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Administration of a diphosphonate in urinary calculi prevention].
    Baumann JM; Ganz U; Bisaz S; Fleisch H; Rutishauser G
    Helv Chir Acta; 1974 Sep; 41(4):421-4. PubMed ID: 4369478
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of diuretic therapy on spontaneous expulsion of urinary calculi, urinary pH, and crystalluria in lithiasic patients].
    Kaid-Omar Z; Belouatek A; Driouch A; Taleb-Bendiab H; Lacour B; Addou A; Daudon M
    Prog Urol; 2001 Jun; 11(3):450-7. PubMed ID: 11512457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.